This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs) targeting central nervous system disorders. Its structure, featuring a dihydrobenzofuran core and an amine group, makes it a valuable intermediate for designing drugs with potential antidepressant, anxiolytic, or antipsychotic properties. The presence of the fluorine atom enhances its metabolic stability and bioavailability, which is crucial for optimizing drug efficacy. Researchers often explore its derivatives for their ability to modulate neurotransmitter systems, such as serotonin or dopamine receptors, contributing to the development of novel therapeutic agents for mental health conditions. Additionally, it may be employed in preclinical studies to evaluate pharmacokinetics, toxicity, and pharmacological activity.